Satellos Bioscience Inc. (MSLE) stock
MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 27, 2026Score 5/30
$5.94−0.26 (-4.19%)
Close on Nov 18, 2026Market cap $91.83MP/E –Yield –
Satellos Bioscience cash
Cash and short-term investments held at the end of each period.
Satellos Bioscience's cash was $9.80M at Dec 31, 2025. For fiscal 2025 it was $9.80M, down 75.5% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.80M | -75.5% |
| FY2024 | Dec 31, 2024 | $40.07M | +140.2% |
| FY2023 | Dec 31, 2023 | $16.68M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $9.80M | – |
| Q4 FY2024 | Dec 31, 2024 | $40.07M | – |
| Q4 FY2023 | Dec 31, 2023 | $16.68M | – |
See a number that looks wrong?